Shanghai Sigma-Audley New Material Technology: difference between revisions
Diff·revision 19 → 20·21:53, 21 Jan 2025
Difference between revision 19 and revision 20 of Shanghai Sigma-Audley New Material Technology. 3 lines changed; the page grew by 526 bytes.
| Revision 19 — 21:11, 17 Jan 2025 PurityClaimPia (talk) expand §Operations and documentation practice 5,169 bytes +159 | Revision 20 — 21:53, 21 Jan 2025 PlainNumbersPip (talk) fix unit 5,695 bytes +526 | ||
|---|---|---|---|
| 30 | Reports reaching this wiki describe vialled lyophilised material with a batch-specific certificate, packaged with a cold pack for the incretin analogues.{{r|reports}} Packaging descriptions have been consistent enough across submissions to suggest a settled fulfilment process, which is a modest but real observation about an organisation of this type. | 30 | Reports reaching this wiki describe vialled lyophilised material with a batch-specific certificate, packaged with a cold pack for the incretin analogues.{{r|reports}} Packaging descriptions have been consistent enough across submissions to suggest a settled fulfilment process, which is a modest but real observation about an organisation of this type. |
| 31 | 31 | ||
| + | 32 | The organisation's own material describes a product range and documentation practice; it makes no certification claim that this wiki has been able to corroborate, and any such claim would in any case require assessment against the applicable framework rather than acceptance at face value.{{r|gmp,selfpub}} | |
| + | 33 | ||
| 32 | == References == | 34 | == References == |
| 33 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 38 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 39 | 42 | ||
| 40 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} | 43 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} |